NDC for Capecitabine (Xeloda®) 500 mg. Dosage Form - European Formulation Blister Pack

Posted May 06, 2011

The Pricing, Data Analysis, and Coding Contractor (PDAC) has the new NDC for this preparation of capecitabine included in the NDC Crosswalk posted on http://www.dmepdac.com.

NDC number 00004-1101-75 for the European version of Xeloda 500 mg. dosage form in the blister pack is effective for claims with dates of service on or after 03/29/2011 received by the DME MAC on or after 05/09/2011.

Refer to the Oral Anticancer Drug LCD and Policy article for additional information.

            Last Updated Tue, 27 Feb 2018 11:42:36 +0000